PFIZER INC (PFE) vs VISA INC.(V)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | PFE | V |
|---|---|---|
| Sector | Health Care | Industrials |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $62.58B | $40.00B |
| Revenue growth (YoY) | ▼ 1.6% | ▲ 11.3% |
| Net income | $7.81B | $20.06B |
| Gross margin | — | — |
| Diluted EPS | $1.36 | — |
| Insider net (6 mo) | +130.5K sh · 2 sells · 3 buys | −38.5K sh · 9 sells · 0 buys |
| Institutional owners | 44 | 55 |
| Institutional value held | $61.93B | $310.89B |
| Next earnings (est.) | Nov 3, 2026 | Oct 27, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
About VISA INC. (V)
Visa Inc. is a global payments technology company that facilitates commerce and money movement across more than 200 countries and territories, connecting consumers, merchants, financial institutions, and government entities through its proprietary network, Vis
Source: SEC EDGAR.